» Articles » PMID: 15963693

Regional Striatal Volume Abnormalities in Schizophrenia: Effects of Comorbidity for Alcoholism, Recency of Alcoholic Drinking, and Antipsychotic Medication Type

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2005 Jun 21
PMID 15963693
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Striatal structures form critical nodes of multiple circuits that are implicated in the pathophysiology of schizophrenia and alcoholism. Here, we examined the separate and combined effects of schizophrenia and alcoholism and effects of medication type and drinking recency on striatal volumes. Accordingly, we measured caudate nucleus, putamen, and nucleus accumbens in 27 schizophrenic, 25 alcohol-dependent, 19 comorbid (schizophrenia and alcohol dependence or abuse), and 51 age-matched control men. Schizophrenics were classified by antipsychotic medication (typical or atypical), and alcoholics were classified by recency of sobriety. All measured structures were smaller in the patient groups than the control group. The caudate deficit was comparable across groups, whereas putamen and nucleus accumbens deficits were greater in schizophrenia than alcoholism; comorbids fell between these groups. Schizophrenic patients treated with atypical medication showed greater volume deficits in the putamen than those treated with typical medication. Recently sober (<3 weeks) alcoholics had greater deficits in nucleus accumbens than longer sober drinkers. In conclusion, caudate, putamen, and nucleus accumbens exhibited different patterns of volume deficit in patients with alcoholism and schizophrenia alone, with no evidence for compounded deficits in comorbid patients. Further, these cross-sectional data provide indirect support for at least partial recovery of nucleus accumbens volume with sobriety in alcoholics, regardless of schizophrenia comorbidity.

Citing Articles

Subcortical Brain Volume Abnormalities in Individuals With an At-risk Mental State.

Sasabayashi D, Takayanagi Y, Takahashi T, Katagiri N, Sakuma A, Obara C Schizophr Bull. 2020; 46(4):834-845.

PMID: 32162659 PMC: 7342178. DOI: 10.1093/schbul/sbaa011.


Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.

Stoychev K Front Psychiatry. 2019; 10:702.

PMID: 31708805 PMC: 6819501. DOI: 10.3389/fpsyt.2019.00702.


Variation in fourteen brain structure volumes in schizophrenia: A comprehensive meta-analysis of 246 studies.

Kuo S, Pogue-Geile M Neurosci Biobehav Rev. 2019; 98:85-94.

PMID: 30615934 PMC: 6401304. DOI: 10.1016/j.neubiorev.2018.12.030.


Impact of substance use disorder on gray matter volume in schizophrenia.

Quinn M, McHugo M, Armstrong K, Woodward N, Blackford J, Heckers S Psychiatry Res Neuroimaging. 2018; 280:9-14.

PMID: 30121336 PMC: 6815746. DOI: 10.1016/j.pscychresns.2018.08.002.


Imaging resilience and recovery in alcohol dependence.

Charlet K, Rosenthal A, Lohoff F, Heinz A, Beck A Addiction. 2018; 113(10):1933-1950.

PMID: 29744956 PMC: 6128779. DOI: 10.1111/add.14259.